Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for the Treatment of Anorexia Nervosa
NCT00140426Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Aug 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anorexia nervosa (AN) comparing placebo with risperidone (2 arms). Primary endpoints: Eating Disorder Inventory-2 Drive for Thinness Subscale at 1 month, Eating Disorder Inventory-2 Score for Body Dissatisfaction at 1 month and 6 more. Started Aug 2004; status: completed.
02
Drugs
risperidone
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00140426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140426.